Prediction Case File
YouTubeEvaluation Complete

Concord Medical Services Holdings Limited Stock Prediction and Forecast [CCM]

1 extracted signal · 1 resolved · 0 still active

StockInvest.us profile imageStockInvest.us18 Oct 2025, 03:48 UTC
Video preview for Concord Medical Services Holdings Limited Stock Prediction and Forecast [CCM]
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
0
Canonical correct result
Failed
1
Canonical failed result
Resolved success
0%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analysis assesses Concord Medical Services Holdings (CCM) with a primarily bearish outlook. The score data ranks CCM as a strong sell candidate with a score of -5.800 as of October 17, 2025. The 3-month trend projects a potential change between -15.15% and -50.25%. However the 12 month shows a price of $4.46 and $9.59 over the next year. The recent sector notes flagged CCM and worries of momentum traders. Technical signals indicate sell recommendations from short and long-term moving averages. The first resistance is expected $5.74. The stock is expected to open at $5.53 and a buy signal is 42 days ago.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

StockInvest.us

Tracked signals
1521
Historical success
43.3%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.